Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
Chen YP, Wang YQ, Lv JW, Li YQ, Chua MLK, Le QT, Lee N, Colevas AD, Seiwert T, Hayes DN, Riaz N, Vermorken JB, O'Sullivan B, He QM, Yang XJ, Tang LL, Mao YP, Sun Y, Liu N, Ma J. Chen YP, et al. Among authors: colevas ad. Ann Oncol. 2019 Jan 1;30(1):68-75. doi: 10.1093/annonc/mdy470. Ann Oncol. 2019. PMID: 30407504 Free article.
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.
Clark JR, Busse PM, Norris CM Jr, Andersen JW, Dreyfuss AI, Rossi RM, Poulin MD, Colevas AD, Tishler RB, Costello R, Lucarini JW, Lucarini D, Thornhill L, Lackey M, Peters E, Posner MR. Clark JR, et al. Among authors: colevas ad. J Clin Oncol. 1997 Sep;15(9):3100-10. doi: 10.1200/JCO.1997.15.9.3100. J Clin Oncol. 1997. PMID: 9294473
Head and neck cancers.
Pfister DG, Ang KK, Brizel DM, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf GT, Worden F; National Comprehensive Concer Network. Pfister DG, et al. Among authors: colevas ad. J Natl Compr Canc Netw. 2011 Jun 1;9(6):596-650. doi: 10.6004/jnccn.2011.0053. J Natl Compr Canc Netw. 2011. PMID: 21636536 Review. No abstract available.
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial.
Lee NY, Zhang Q, Pfister DG, Kim J, Garden AS, Mechalakos J, Hu K, Le QT, Colevas AD, Glisson BS, Chan AT, Ang KK. Lee NY, et al. Among authors: colevas ad. Lancet Oncol. 2012 Feb;13(2):172-80. doi: 10.1016/S1470-2045(11)70303-5. Epub 2011 Dec 15. Lancet Oncol. 2012. PMID: 22178121 Free PMC article. Clinical Trial.
Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.
Tang C, Murphy JD, Khong B, La TH, Kong C, Fischbein NJ, Colevas AD, Iagaru AH, Graves EE, Loo BW Jr, Le QT. Tang C, et al. Among authors: colevas ad. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1514-20. doi: 10.1016/j.ijrobp.2011.10.023. Epub 2012 Jan 21. Int J Radiat Oncol Biol Phys. 2012. PMID: 22270174 Free PMC article.
186 results